Skip to content

Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station

Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02856633
Enrollment
40
Registered
2016-08-05
Start date
2016-07-31
Completion date
2017-05-31
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Otitis Media, Atrial Fibrillation, COPD, Diabetes Mellitus, Healthy Volunteers, Hypertension, Iron Deficient Anemia, Leukocytosis, OSA, Pneumonia, Urinary Tract Infection

Brief summary

The study objective is to satisfy the testing requirements for the Qualcomm Tricorder XPRIZE Competition. This requires an oversight model using the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station to continuously monitor the patient's five core vital signs and to detect the health conditions required by the competition.

Interventions

DEVICEVitaliti

Sponsors

Cloud DX Inc.
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 to 65 years of age. * English speaking * Established diagnosis of one of the thirteen required conditions with evidence in Medical Record.

Exclusion criteria

* Lack of patient consent * Has pacemaker or internal medical device * Pregnancy * Concurrent enrollment into a clinical trial that may affect subject treatment * Age less than 18 or over 65 * Physical disabilities affecting vision (eyeglasses or contact lenses will be allowed), manual manipulation, or use of a computer or mobile device

Design outcomes

Primary

MeasureTime frame
Successful diagnosis of patient's condition by Vitaliti software as compared to patient's Medical Record90 minutes

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026